Pyridostigmine BR 60 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQHBT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,059
Award facts
- Contract value 100% obligated
- $2,059.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,059.09 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 60 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion and extends through December 2026, providing comprehensive global pharmaceutical support to military healthcare programs.
Pyridostigmine bromide is a cholinesterase inhibitor commonly used to treat myasthenia gravis and other neuromuscular conditions within military healthcare systems. This delivery order exemplifies the routine pharmaceutical procurement conducted through AmerisourceBergen's established IDC vehicle, which enables the Defense Logistics Agency to efficiently source brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's capability to fulfill both small-value transactions and substantial orders demonstrates its critical role in supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms designed to meet dynamic military medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FQHBT?
SPE2DB25FQHBT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FQHBT worth?
The government has obligated $2,059 on SPE2DB25FQHBT.
Is contract SPE2DB25FQHBT an order under another contract?
Yes. SPE2DB25FQHBT is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQHBT competed?
The extent of competition for SPE2DB25FQHBT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award